A 3-year-old boy from Delhi presents with recurrent episodes of vomiting, lethargy, and developmental delay. Serum ammonia is 180 µmol/L (normal <50). Plasma amino acid profile shows elevated glutamine and alanine. Urine orotic acid is markedly elevated. Genetic testing confirms ornithine transcarbamylase (OTC) deficiency. What is the most appropriate immediate management?

Explanation

## Acute Hyperammonemia Management in OTC Deficiency ### Pathophysiology OTC deficiency blocks the conversion of carbamoyl phosphate and ornithine to citrulline, causing: - Accumulation of carbamoyl phosphate → shunting to pyrimidine synthesis → elevated urinary orotic acid (pathognomonic) - Severe hyperammonemia (ammonia cannot be incorporated into urea) - Neurological toxicity from ammonia and glutamine accumulation ### Immediate Management Strategy **Key Point:** In acute symptomatic hyperammonemia (ammonia >150 µmol/L with CNS signs), the priority is rapid ammonia reduction via: 1. **High-dose IV arginine** — bypasses the OTC block by providing an alternative substrate for nitrogen disposal via the arginine-dependent pathways (arginine → creatine, polyamines, nitric oxide) 2. **Protein restriction** — immediately reduce nitrogen load to minimize ammonia generation 3. **Supportive care** — IV dextrose, correction of electrolytes **High-Yield:** Arginine is BOTH a urea cycle intermediate AND a signaling molecule that upregulates ammonia-scavenging pathways. In OTC deficiency, it is the rate-limiting amino acid and must be repleted immediately. ### Why This Patient Needs IV Arginine First - Ammonia level (180 µmol/L) is in the danger zone (>150 = acute encephalopathy risk) - Patient is symptomatic (lethargy, vomiting) → acute decompensation - Arginine restores urea cycle flux at the citrulline synthase step and activates N-acetylglutamate synthase ### Adjunctive Therapy (After Stabilization) - Sodium benzoate and sodium phenylbutyrate are used for **chronic/maintenance** management, not acute crisis - Benzoate conjugates glycine → hippurate (removes 1 N per molecule) - Phenylbutyrate → phenylacetate → conjugates glutamine → phenylacetylglutamine (removes 2 N per molecule) ### Why Hemodialysis Is Not First-Line - Dialysis is reserved for **refractory hyperammonemia** (>300 µmol/L) or when medical therapy fails - Current ammonia level is manageable with pharmacotherapy - Dialysis has limited ammonia clearance because ammonia is a small, lipophilic molecule that crosses membranes slowly **Clinical Pearl:** The classic triad of OTC deficiency presentation: (1) elevated ammonia, (2) elevated urinary orotic acid, (3) normal or low plasma citrulline (because citrulline synthase is blocked upstream). [cite:Harrison 21e Ch 355]